To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05885464
Title A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Beam Therapeutics Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Stanford University School of Medicine Stanford California 94304 United States Details
Colorado Blood Cancer Institute Denver Colorado 80218 United States Details
University of Chicago Chicago Illinois 60637 United States Details
The University of Kansas Cancer Center Fairway Kansas 66205 United States Details
Dana Farber and Boston Children's Hospital Boston Massachusetts 02115 United States Details
Cleveland Clinic- Taussig Cancer Center Cleveland Ohio 44106 United States Details
OHSU Knight Cancer Institute Hematology Oncology Portland Oregon 97239 United States Details
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 United States Details
Sarah Cannon- TriStar Bone Marrow Transplant Nashville Tennessee 37203 United States Details
Methodist Hospital - Texas Transplant Institute San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field